OBJECTIVE: Peripartum cardiomyopathy (PPCM) is a rare disease, and it is associated with high maternal morbidity and mortality. Multifetal pregnancy is a well-known risk factor for PPCM, but the exact incidence and clinical features of PPCM in multifetal pregnancy has not been reported. Thus, this study aimed to evaluate the frequency, clinical and echocardiographic characteristics, and outcomes of PPCM in multifetal pregnancy, especially in triplet pregnancy. STUDY DESIGN: We identified 30 women complicated with PPCM among 18,132 women who delivered at Seoul National University Hospital from January 2005 to May 2018. We defined PPCM as follows: 1) heart failure in the last month of pregnancy or within five months postpartum without underlying heart diseases or identifiable causes of heart failure; and 2) on echocardiography, left ventricular end diastolic dimension > 2.7cm/m 2 with ① left ventricular ejection fraction (EF) <45% or ② fractional shortening <30%. With dividing women with PPCM into three groups according to the number of fetuses (singleton, twin and triplet pregnancy), we compared the frequency, clinical and echocardiographic characteristics, and outcomes of PPCM among them. RESULTS: The frequency of PPCM increased with fetal number: 0.1% (14/14,291), 0.3% (10/3,487) and 1.7% (6/354) in singleton, twin and triplet pregnancies, respectively (P<0.05). The level of brain natriuretic peptide increased with fetal number, and the left ventricular function at echocardiography showed a gradual deterioration with increasing fetal number (Table) . Recovery rate of heart function at follow-up echocardiography within 50 days also significantly lower in multifetal pregnancy (71.4%, 16.7% and 0% in singleton, twin and triplet pregnancy, P<0.05). CONCLUSION: PPCM in triplet pregnancy is more frequent and shows worse left ventricular function at diagnosis, compared to that in singleton and twin pregnancy. Close observation should be considered in triplet pregnancy for early detection and timely management of PPCM.
380 Fascia lata versus placental specimens for genetic testing after IUFD: success rates and financial cost Tahseen I. Ahmed, Maureen Burke SUNY Upstate University, Syracuse, NY OBJECTIVE: Fascia lata and placental specimens are commonly collected for genetic testing of fetal cells after intrauterine fetal demise (IUFD). ACOG guidelines recommend collection of placental specimens over fascia lata, as placenta has better tissue culture success rates. However, at many institutions, fascia lata for IUFDs continues to be collected routinely. This study compares success rates and financial costs of these two tissue sources in providing viable cells for karyotype analysis after IUFD. STUDY DESIGN: A retrospective chart review was performed for patients with a diagnosis of IUFD admitted to a single academic institution from 2015 to 2017. We identified patients for which fetal fascia lata and/or placental specimen was collected for karyotyping.
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